Table 3 Comparison among three studies on NAION and SAS.
| Palombi et al12 | Mojon et al11 | Current study | |||
|---|---|---|---|---|---|
| NAION N = 27 | NAION N = 17 | Controls N = 17 | NAION N = 73 | Controls N = 73 | |
| Gender | |||||
| Male, n (%) | 18 (67) | 15 (88) | 15 (88) | 38 (52) | 38 (52) |
| Female, n (%) | 9 (33) | 2 (12) | 2 (12) | 36 (48) | 35 (48) |
| Age | 65.0±8.0 | 64.6±11.7 | 63.3±11.0 | 63.5±11.0 | 63.5±11.0 |
| BMI | 27.2±3.8 | 27.5±4.8 | 27.6±3.9 | 28.1±5.9 | 28.4±5.9 |
| Hypertension (%) | 49 | 53 | 29 | 60 | 51 |
| Diabetes (%) | 26 | 12 | 18 | 29 | 26 |
| SAS (%) | 89 | 71 | 18 | 30.1 | 17.8 |